• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2009 Fiscal Year Final Research Report

Role of Peroxiredoxin on Metabolic Syndorome

Research Project

  • PDF
Project/Area Number 19590413
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Experimental pathology
Research InstitutionUniversity of Occupational and Environmental Health, Japan

Principal Investigator

SASAGURI Yasuyuki  University of Occupational and Environmental Health, Japan, 医学部, 教授 (60140646)

Co-Investigator(Kenkyū-buntansha) KOHNO Kimitoshi  産業医科大学, 医学部, 教授 (00153479)
Project Period (FY) 2007 – 2009
Keywords疾患モデル動物
Research Abstract

1 We generated human PRDX4 (hPRDX4) transgenic (Tg) mice, displaying a high level of hPRDX4 expression in the pancreatic islets, and then focused on the functions of PRDX4 in a type 1 diabetes mellitus (T1DM) model using a single high dose of streptozotocin (SHDS). After SHDS-injection, Tg mice showed significantly less hyperglycemia and hypoinsulinemia and a much faster response on glucose tolerance test than wild type (WT) mice. Upon comparison between these two mouse models, β-cell apoptosis was also repressed, and reversely, β-cell proliferation was enhanced in Tg mice. Real-time RT-PCR demonstrated that the expression of many inflammatory-related molecules and their receptors and transcription factors were significantly down-regulated in Tg mice. These data indicate that PRDX4 can protect pancreatic islet β-cells against injury caused by SHDS-induced insulitis, which strongly suggests that oxidative stress plays an essential role in SHDS-induced diabetes.
2 To define the role of PRDX4 in atherosclerosis, we generated PRDX4-Tg and apoE knockout mice (hPRDX4-Tg/apoE^<-/-> mice). En-face quantitative and sectinal analysis of aortas demonsurated that atheroscleroosis in hPRDX4-Tg/apoE^<-/-> mice fed a 1.25% cholesterol diet for 12 wk were decreased up-to 40-50% compared with apoE^<-/->. These indicate that PRDX4 may be a suppressive factor for the progression of atherosclerosis.

  • Research Products

    (2 results)

All 2010 2009

All Journal Article (1 results) (of which Peer Reviewed: 1 results) Presentation (1 results)

  • [Journal Article] OVEREXPRESSION OF PEROXIREDOXIN4 PROTECTS AGAINST HIGH-DOSE STREPTOZOTOCIN-INDUCED DIABETES BY SUPPRESSING OXIDATIVE STRESS AND CYTOKINES IN TRANSGENIC MICE2010

    • Author(s)
      YAN DING, 1 SOHSUKE YAMADA, 1KE-YONG WANG, 1 SHOHEI SHIMAJIRI, 1 XIN GUO, 1 AKIHIDE TANIMOTO, 2, 1 SHUJI KITAJIMA, 3 TERUO WATANABE, 4 HIROTO IZUMI, 5 KIMITOSHI KOHNO, 5 YASUYUKI SASAGURI1
    • Journal Title

      Antioxidants & Redox Signaling (in press)

    • Peer Reviewed
  • [Presentation] The role of PeroxiredoxinIVin Diabetes Mellitus2009

    • Author(s)
      丁妍
    • Organizer
      第98回日本病理学会
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2009-05-03

URL: 

Published: 2011-06-18   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi